In conclusion, with the exception of TLR5, hepatic TLRs, upon binding by gut bacteria-derived products, set into motion a cascade of inflammatory and fibrotic signals, thereby abetting the progression of fatty liver to NASH. Here, TLR5 is linked to metabolic dysfunction-associated steatohepatitis.